Table 2.

Characteristics of AYA transmen who underwent fertility preservation consultation with a Reproductive Endocrinology and Infertility physician.

	Declined Fertility Preservation	Underwent Oocyte Cryopreservation	P value
	n = 15	n = 20
General Characteristics of Referrals
Age at consultation [years, median (range)]	18 (10-24)	16 (12-23)	0.16
Age at gender identity affirmation [years, median (range)]	12 (9-17)	14 (11-21)	0.56
Time between Gender Affirmation and Consult [years, median (range)]	2 (1-13)	2 (1-4)	0.56
Pre-Consultation Gender Affirming Treatments
Menstrual suppression with oral contraception	27% (4/15)	15% (3/20)	0.31
Pubertal blocker with leuprolide acetate	20% (3/15)	10% (2/20)	0.63
Testosterone	33% (3/15)	10% (2/20)	0.63
Gender Affirmatory Top Surgery	27% (4/15)	5% (1/20)	0.14
Post-Consultation Gender Affirming Treatments
Menstrual suppression with oral contraception	27% (4/15)	15% (3/20)	0.31
Menstrual suppression with leuprolide acetate	27% (4/15)	10% (2/20)	0.39
GNRH implant	0% (0/15)	5% (1/20)	1.00
Testosterone	47% (7/15)	70% (14/20)	0.69
Gender Affirmatory Top Surgery	53% (8/15)	45% (9/20)	0.28
Gender Affirmatory Bottom Surgery	7% (1/15)	5% (1/20)	1.00
Fertility Goals
Unsure of desire of future biological children (%)	53% (8/15)	55% (11/20)	0.67
Certain of desire of future biological children (%)	13% (2/15)	25% (5/20)
No documentation of desire of future biologic children (%)	33% (5/15)	20% (4/20)